Vibrant Wellness: Cardio Zoomer with Genetics

Vibrant Wellness: Cardio Zoomer with Genetics

$1,095.00

Cardiac Zoomer with Genetics

If you’ve been told your cholesterol looks ‘fine’ but something still feels off — or if heart disease runs in your family and you refuse to just wait and see — this test is worth a serious look. I’ve spent over 25 years in clinical practice watching people get dismissed with a basic lipid panel that misses 80% of what actually drives cardiovascular events. The Cardiac Zoomer with Genetics from Vibrant Wellness is a different animal entirely, and I want to break it down for you the way I’d explain it to a patient sitting across from me.

What Is the Cardiac Zoomer with Genetics?

The Cardiac Zoomer is a comprehensive blood and urine panel that goes layer by layer through your cardiovascular system — endothelial function, advanced lipids, inflammation, oxidative stress, omega status, clotting markers, ceramides, sterol balance, and cardiac stress indicators. Then the Genetics add-on layers in your DNA — the inherited tendencies that explain why your cholesterol behaves the way it does, how your blood pressure is regulated at the gene level, and how your body responds to medications like statins.

Together, these two tests tell you what is happening right now AND what you were wired to be susceptible to. That combination is genuinely rare in the direct-to-consumer testing world, and it’s exactly the kind of root-cause picture I look for when working with patients who have complex or unexplained cardiovascular patterns.

What the Cardiac Zoomer Measures

1. Endothelial Function — The Nitric Oxide Pathway

This is where the test sets itself apart from anything you’ll get at a standard clinic. The endothelium — the thin lining of your blood vessels — is where cardiovascular disease often starts, silently, years before a diagnosis. The Cardiac Zoomer measures arginine, citrulline, homoarginine, ADMA, and SDMA, along with the key ratios between them.

Here’s what those numbers tell you: when ADMA is elevated, it blocks nitric oxide production, which means your blood vessels can’t relax properly. When arginine is low relative to ADMA, you have a nitric oxide deficit even if your cholesterol looks perfect on paper. This is the kind of upstream dysfunction that precedes hypertension, arterial stiffness, and plaque formation — and most people have never had it measured.

2. Advanced Lipids and Particle Burden

ApoB is arguably the most important lipid marker most people have never been tested for. It counts the actual number of plaque-forming particles in circulation — LDL, remnants, and Lp(a) — not just the cholesterol content inside them. You can have a “normal” LDL-C and still carry a dangerously high particle burden. The panel also includes direct LDL-C, HDL-C, triglycerides, ApoA-1, and small-dense LDL — the oxidized, artery-penetrating subtype that’s far more harmful than regular LDL.

And then there’s Lp(a). This is the cardiovascular risk factor that almost nobody talks about in primary care. Lp(a) is genetically determined — lifestyle barely moves it — and elevated levels significantly raise your lifetime risk of atherosclerosis and aortic valve calcification. If you have a family history of early heart disease and you’ve never had your Lp(a) measured, that’s the gap this test fills.

3. Ceramides — The Hidden Plaque Signal

Ceramides are bioactive fats that drive inflammation and plaque instability. The research on ceramide ratios as cardiac risk markers is some of the most compelling data to emerge in cardiovascular medicine in the past decade. What makes ceramides particularly valuable is that they can predict cardiovascular events in patients whose LDL looks fine. If your particle burden is high or your ceramide ratios are elevated, that’s a strong signal that your artery environment is genuinely dangerous, regardless of what your standard cholesterol panel says.

4. Sterol Balance — Production vs. Absorption

This is one of my favorite parts of the panel because it directly informs the therapeutic approach. The test distinguishes between cholesterol your liver is overproducing (lathosterol and desmosterol) versus cholesterol you’re overabsorbing from the gut (campesterol and beta-sitosterol). That distinction matters because the intervention is completely different. An overproducer needs a different strategy than an overabsorber. Without this data, you’re guessing.

5. Inflammation and Oxidative Stress

The inflammation panel here is thorough: hsCRP, homocysteine, IL-6, TNF-alpha, MPO (myeloperoxidase), PLAC/Lp-PLA2 activity, and oxidized LDL. Each of these tells a different piece of the inflammatory story. hsCRP is your global inflammation signal. MPO tells you whether plaque is actively oxidizing lipids and becoming vulnerable. Oxidized LDL is the specific form of LDL that triggers foam cell formation and unstable plaque. If you have elevated oxLDL alongside elevated MPO, you have an active, hot inflammatory process happening inside your arteries — and that requires a different approach than elevated cholesterol alone.

Homocysteine also earns its place here. It’s influenced by B-vitamin status, methylation genetics, kidney function, and thyroid — all things I evaluate routinely in functional medicine practice, and all things that a conventional lipid panel completely ignores.

6. Omega-3 Panel

The omega-3 index — the percentage of EPA and DHA in your red blood cells — is one of the strongest predictors of fatal cardiac events that almost no one measures. An omega-3 index below 4% roughly doubles cardiovascular risk compared to an index above 8%. The panel breaks down EPA, DPA, DHA, linoleic acid, and arachidonic acid, giving you a complete picture of your omega-3 to omega-6 balance and exactly where supplementation may need to focus.

7. Cardiac Stress and Clotting Markers

NT-proBNP (cardiac strain), D-dimer (active clotting and fibrinolysis), troponin-T (heart muscle injury), and creatine kinase (muscle injury, relevant if you’re on statins or have post-exercise symptoms) round out the panel. These aren’t markers for self-diagnosis — if they’re abnormal, that’s a conversation with your clinician. But having them as part of a comprehensive baseline is far more informative than waiting for symptoms.

The Cardio Genetics: Your Lifelong Blueprint

DNA doesn’t change. That’s what makes this add-on a one-time investment that pays dividends for the rest of your life. The Cardio Genetics panel screens genes across five major domains:

  • Lipoproteins and triglycerides — LPA, LDLR, APOB, PCSK9, APOE, LPL, CETP, and more. These are the genes that determine whether your LDL and Lp(a) are genetically elevated, how well you clear triglycerides, and how efficiently your HDL performs its cleanup role.
  • Vascular and blood pressure regulation — ACE, AGTR1, AGT, NOS3, CYP4A11, CYP4F2. These genes govern your RAAS set-point, salt sensitivity, and nitric oxide production capacity.
  • Inflammation and oxidative stress — PON1 (HDL-bound antioxidant enzyme), MPO (plaque vulnerability), HDAC9 (large-artery stroke risk).
  • Clotting tendencies — Factor V Leiden (F5), Prothrombin (F2), and PLG variants that influence how your body forms and clears clots.
  • Pharmacogenomics — SLCO1B1, CYP3A5, ABCG2 for statin safety and dosing; CYP2C19 for clopidogrel activation; CYP1A2 for caffeine clearance and its effects on blood pressure and arrhythmia risk.

This last category is one I want to highlight directly. If you carry a CYP2C19 loss-of-function variant, you cannot properly activate clopidogrel — one of the most commonly prescribed antiplatelet drugs after a cardiac event. That is life-critical pharmacogenomic information that most patients never receive. Knowing it in advance means your clinician can choose the right medication from the start rather than discovering the issue after it fails.

Not Available in NY

MyLabsForLife is not responsible for blood draw services

Results Emailed Via Secure Email: 14-21 Days

Requires fasting at least 8 hours prior to lab draw

Blood Collection

Urine Collection

Sample Report

Cardio Marker List

Cardio Genetics Information

Categories: , , , , , , Tags: , , , , , , , , ,

Who Is This Test Right For?

In my clinical experience, this test is particularly well-suited for:

  • Anyone with a family history of early heart disease or premature cardiac events — especially if they’ve been told their cholesterol is “normal” and can’t understand why their relatives had heart attacks in their 50s.
  • People with stubborn or genetically-driven lipid patterns — elevated Lp(a), high particle burden despite clean diet, or LDL that doesn’t budge with lifestyle changes.
  • Endurance athletes and high performers — who want to understand their endothelial and oxidative stress status, not just their cholesterol.
  • Anyone with borderline blood pressure, glucose, or inflammatory markers who wants to understand the root driver before committing to medication.
  • Patients who are being offered statin therapy or antiplatelet drugs and want pharmacogenomic guidance to help their provider choose wisely.
  • People who have been dismissed by conventional medicine despite persistent symptoms or a strong gut feeling that something is wrong with their cardiovascular system.

What the Report Looks Like

The report is genuinely well-designed. You get a summary dashboard with Framingham and Reynolds 10-year risk scores, category meters for each domain, a nitric oxide pathway graphic that visualizes your endothelial function, a lipoprotein diagram, and a sterol balance gauge. The genetics section includes a RAAS schematic and pharmacogenomic drug-response wheels. At the end, there’s a personalized suggestions page covering nutrients, botanicals, food sources, and adaptogens — comprehensive, but not meant to be acted on in isolation. This is something to bring to a clinician who can help you prioritize.

The Framingham Risk Score uses the classic variables most cardiologists know. The Reynolds Risk Score adds high-sensitivity CRP and parental cardiac history — which makes it more relevant for people whose inflammation is driving risk that the Framingham calculation underestimates. Having both gives you a more complete picture.

How the Process Works

You order the Cardiac Zoomer (with or without the Genetics add-on), receive a collection kit, and have a standard venous blood draw plus a small urine sample collected at a local phlebotomy site. Fast for at least 8 hours beforehand and schedule your draw Monday through Thursday to ensure proper sample transit. The lab is CLIA/CAP certified.

Once results come back, the real work begins: translating what those markers mean for your specific situation and building a phased, evidence-based protocol that addresses the root causes rather than just chasing individual numbers.

A Note on Genetics and Destiny

Genetics sets the terrain. It doesn’t write the final chapter. Every variant on this panel represents a tendency — not a sentence. The reason I value the Cardio Genetics add-on so highly is precisely because it removes the guesswork from prevention. Instead of applying a generic heart-healthy protocol, you’re working with a map of your specific vulnerabilities and calibrating the intervention to match.

Sleep, stress management, oral health, physical activity, nutrition, and targeted supplementation — these are the levers that determine how your genetic blueprint actually expresses. Knowing where you’re vulnerable allows you to apply those levers with precision.

Bottom Line

The Cardiac Zoomer with Genetics is the most comprehensive direct-to-consumer cardiovascular risk assessment I’ve seen. It addresses the full picture — not just what your cholesterol is doing today, but why it’s doing it, what your arteries look like from an inflammation and oxidative stress standpoint, how your endothelium is functioning, whether you have active clotting signals, and what your genes are contributing to the whole picture.

If you’ve been waiting for a test that treats heart disease prevention as the serious, root-cause investigation it deserves to be — this is it. Order it with the Genetics add-on. Do it once. Use the data to make smarter decisions for the rest of your life.

Why This Matters: Prevention Is a Power Move

Cardiovascular health isn’t just about avoiding a heart attack. It’s about:

  • Energy and stamina

  • Brain health and circulation

  • Sexual health and blood flow

  • Resilience with aging

  • Recovery capacity after illness

  • Longevity with quality of life

I’m a big believer in this: you don’t have to wait for a crisis to care about your heart. Information creates options. Options create power.

When you understand your risk pattern early, you can make changes that are often simpler than people expect—especially when they’re targeted and personalized.

Important Notes (Clinical Boundaries)

  • This test is for health information and wellness insights.

  • It is not designed to diagnose, treat, cure, or prevent disease on its own.

  • If you have chest pain, shortness of breath, fainting, stroke-like symptoms, or urgent concerns, seek emergency care.

  • Medication decisions should always be made with a licensed prescribing clinician who knows your history.

  • Be sure to discuss your test results and health concerns with a qualified health care provider.

Frequently Asked Questions

Is this test a diagnosis?

No. The Cardiac Zoomer with Genetics is a risk-assessment and health-optimization tool. It is performed in a CLIA/CAP-certified laboratory and provides meaningful clinical data, but results should always be interpreted in the context of your full medical history by a qualified clinician.

Do I need to fast before the blood draw?

Yes — at least 8 hours of fasting is recommended before your blood draw. Schedule your collection Monday through Thursday to ensure proper sample handling and transit to the lab.

Can lifestyle changes still make a difference if I have genetic risk variants?

Absolutely. Genetics provides a baseline tendency, not a fixed outcome. The value of knowing your variants is that it allows you to direct lifestyle interventions — nutrition, movement, stress management, sleep, targeted supplementation — precisely where they’re most needed. Environment and behavior drive the majority of outcomes, even in people with significant genetic predispositions.

How is this different from a standard cholesterol panel?

A standard lipid panel typically measures total cholesterol, LDL-C, HDL-C, and triglycerides. The Cardiac Zoomer adds ApoB, Lp(a), small-dense LDL, ceramides, sterol balance markers, the full nitric oxide pathway, inflammation cytokines, oxidized LDL, omega-3 index, cardiac stress markers, and clotting factors — along with two 10-year risk calculators. The two panels are not comparable in depth or clinical utility.

Why add the Genetics panel to the Cardiac Zoomer?

If you have a family history of heart disease, stubborn lipid patterns, or are considering cardiac medications, I strongly recommend adding the Genetics panel. You test once and use the results indefinitely. The pharmacogenomic insights alone — particularly around statin safety and antiplatelet drug activation — can have a significant real-world impact on the medication choices your provider makes.

Related products